Carmen Valcarce
Chief Scientific Officer & Executive VPDr. Carmen Valcarce, Ph.D. serves as the Chief Scientific Officer of vTv Therapeutics Inc. and has been its Executive Vice President since June 6, 2017. Dr. Valcarce serves as the Chief Scientific Officer and Senior Vice President at TransTech Pharma, Inc., (now known as vTv Therapeutics LLC) and served as its Senior Vice President of Preclinical Research. Dr. Valcarce served as Senior Vice President at vTv Therapeutics Inc. until June 6, 2017. She served as a Vice President of Preclinical Research of TransTech Pharma, Inc. From 1989 to 1998, Dr. Valcarce held the position of Assistant Professor at the Department of Clinical Chemistry at Lund University. During this time, the focus of her research was to understand the structure-function relationship of various coagulation factors as well the EGF-precursor protein. Dr. Valcarce joined Excorim AB in 1998 to pursue the development of a plasmaphoreis-like system suitable to remove anti-Gal antibodies prior to kidney xeno-transplantation. In 2000, she returned to the metabolic disease area and joined Novo Nordisk where she was the project leader of the glucokinase activator project from idea to FHD. Dr. Valcarce is the author of numerous papers and presentations and is an inventor on several patents and patent applications. Dr. Valcarce completed her postdoctoral studies at the Department of Clinical Chemistry at Lund University. Dr. Valcarce obtained her Ph.D. at the Universidad Autonoma de Madrid, Spain in 1988 under the direction of Prof. Jose M. Cuezva in the field of metabolic diseases with focus on mitochondrial development and maturation after birth.
Positions
- Company NamevTv Therapeutics Inc.Stock CodeVTVTPositionChief Scientific Officer & Executive VPColleagues
- PJPaul J. SekhriCEO, President & Chairman of the Board
- MSMichael Steven TungExecutive VP & CFO
- BKBarry K. BrownChief Accounting Officer
- EMElizabeth M. KeileyExecutive VP & General Counsel
- RSRichard S. NelsonExecutive VP of Corporate Development & Director
- RCRaymond CheongLead Independent Director
- AMAnne Michelle PhillipsIndependent Director
- DKDaniel K. SpiegelmanIndependent Director
